Takeda Pharmaceutical Company Limited (4502) Other
Market cap
¥8.14T
P/E ratio
49.1x
Takeda develops and manufactures innovative medicines for gastrointestinal diseases, rare diseases, oncology, neuroscience, vaccines, and plasma therapies worldwide.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Return on Assets | - | - | - | - | 3 | 4 | 5.2 | 1.2 | 0.3 | 2.9 | 1.8 | 2.3 | 1 | 0.7 | 1.3 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 30,305 | 30,481 | 31,225 | 31,328 | 31,168 | 29,900 | 27,230 | 49,578 | 47,495 | 47,099 | 47,347 | 49,095 | 49,281 | 47,455 | - |
| Total payout ratio | - | - | - | - | - | - | 86 | 132.1 | 647.2 | 75.9 | 157 | 96.6 | 201 | 328.3 | 184.2 |